Qu Cheng, Sun Yanbo, Wang Yanxue, Jiang Bo, Jiang Chaoyu, Zhang Chen, Wang Yue, Wang Jingchen, Xi Hua, Chen Yongzhao, Yang Dengyuan, Luo Yuqian, Su Lei
Division of Thyroid Surgery, Department of General Surgery, Nanjing Drum Tower Hospital, the Affiliated Hospital of Medical School, Nanjing University, Nanjing, 210008, China.
Department of Surgery, Ma'anshan Maternal and Child Health Care Hospital, Ma'anshan, Anhui, 243011, China.
BMC Surg. 2025 Jul 28;25(1):317. doi: 10.1186/s12893-025-03041-1.
A Chinese multicenter prospective cohort study of supraclavicular oblique incision sternocleidomastoid intermuscular approach (SOI-SMIA) versus traditional low collar incision linea alba cervicalis approach (TCLI-LACA) in thyroid lobectomy for papillary thyroid carcinoma (LATERAL study) has been initiated. The aim is to compare surgical approach-related outcomes in thyroid lobectomy. We here outline the detailed protocol for this study.
PTC which can be treated by lobectomy is considered for inclusion in the study. Eligible patients will receive printed materials that detail the advantages and disadvantages of each management option, allowing them to select their preferred intervention. Thyroid lobectomy by SOI-SMIA or TCLI-LACA will be performed within 24 h after grouping. We designed a composite index of surgical approach-related trauma as the primary endpoint. It includes both the superficial (scar consciousness and appearance satisfaction) component and the deep component (neck impairment), and will be assessed at 1 month and 6 months after surgery. The LATERAL study will be conducted in three hospitals in China. We plan to recruit 80 patients per group and enroll patients consecutively over time and will conclude once the group with the smaller number of participants reaches 80 cases.
The results of this trial will contribute to confirming the role of SOI-SMIA in thyroid lobectomy for PTC, and provide evidence to support its wider adoption.
一项关于锁骨上斜切口胸锁乳突肌肌间入路(SOI-SMIA)与传统低领切口白线入路(TCLI-LACA)在甲状腺乳头状癌甲状腺叶切除术(LATERAL研究)中的中国多中心前瞻性队列研究已经启动。目的是比较甲状腺叶切除术中手术入路相关的结果。我们在此概述本研究的详细方案。
考虑将可通过叶切除术治疗的甲状腺乳头状癌纳入研究。符合条件的患者将收到详细说明每种治疗方案优缺点的印刷材料,以便他们选择自己偏好的干预措施。分组后24小时内将通过SOI-SMIA或TCLI-LACA进行甲状腺叶切除术。我们设计了一个手术入路相关创伤的综合指数作为主要终点。它包括浅表部分(瘢痕意识和外观满意度)和深部部分(颈部功能障碍),并将在术后1个月和6个月进行评估。LATERAL研究将在中国的三家医院进行。我们计划每组招募80名患者,并随着时间的推移连续招募患者,一旦参与者较少的组达到80例,研究即结束。
本试验的结果将有助于证实SOI-SMIA在甲状腺乳头状癌甲状腺叶切除术中的作用,并为支持其更广泛应用提供证据。